1.
Wu P, Nielsen TE. Petasis three-component reactions for the synthesis of diverse heterocyclic scaffolds. Drug Discov Today Technol. 2018;29:27-33. doi:10.1016/j.ddtec.2018.06.010.
1.
Kawasumi M, Bradner JE, Tolliday N, et al. Identification of ATR-Chk1 pathway inhibitors that selectively target p53-deficient cells without directly suppressing ATR catalytic activity. Cancer Res. 2014;74(24):7534-45. doi:10.1158/0008-5472.CAN-14-2650.
1.
Maetani M, Zoller J, Melillo B, et al. Synthesis of a Bicyclic Azetidine with In Vivo Antimalarial Activity Enabled by Stereospecific, Directed C(sp)-H Arylation. J Am Chem Soc. 2017;139(32):11300-11306. doi:10.1021/jacs.7b06994.
1.
Branon TC, Bosch JA, Sanchez AD, et al. Efficient proximity labeling in living cells and organisms with TurboID. Nat Biotechnol. 2018;36(9):880-887. doi:10.1038/nbt.4201.
1.
Verho O, Maetani M, Melillo B, Zoller J, Schreiber SL. Stereospecific Palladium-Catalyzed C-H Arylation of Pyroglutamic Acid Derivatives at the C3 Position Enabled by 8-Aminoquinoline as a Directing Group. Org Lett. 2017;19(17):4424-4427. doi:10.1021/acs.orglett.7b01776.
1.
Gray L, Schreiber SL. Skeletal diversity in small-molecule synthesis using ligand-controlled catalysis. J Comb Chem. 2007;9(6):1028-35. doi:10.1021/cc7001028.
1.
Luo T, Schreiber SL. Complex alpha-pyrones synthesized by a gold-catalyzed coupling reaction. Angew Chem Int Ed Engl. 2007;46(43):8250-3. doi:10.1002/anie.200703276.
1.
Looper RE, Pizzirani D, Schreiber SL. Macrocycloadditions leading to conformationally restricted small molecules. Org Lett. 2006;8(10):2063-6. doi:10.1021/ol0604724.
1.
Brittain DEA, Gray L, Schreiber SL. From solution-phase to solid-phase enyne metathesis: crossover in the relative performance of two commonly used ruthenium pre-catalysts. Chemistry. 2005;11(17):5086-93. doi:10.1002/chem.200500279.
1.
Kumar N, Kiuchi M, Tallarico JA, Schreiber SL. Small-molecule diversity using a skeletal transformation strategy. Org Lett. 2005;7(13):2535-8. doi:10.1021/ol0504345.